Molecular Mechanisms of Notch Signaling in Lymphoid Cell Lineages Development: NF-κB and Beyond.


Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2020
Historique:
entrez: 20 2 2020
pubmed: 20 2 2020
medline: 3 3 2020
Statut: ppublish

Résumé

Notch is a ligand-receptor interaction-triggered signaling cascade highly conserved, that influences multiple lineage decisions within the hematopoietic and the immune system. It is a recognized model of intercellular communication that plays an essential role in embryonic as well as in adult immune cell development and homeostasis. Four members belong to the family of Notch receptors (Notch1-4), and each of them plays nonredundant functions at several developmental stages. Canonical and noncanonical pathways of Notch signaling are multifaceted drivers of immune cells biology. In fact, increasing evidence highlighted Notch as an important modulator of immune responses, also in cancer microenvironment. In these contexts, multiple transduction signals, including canonical and alternative NF-κB pathways, play a relevant role. In this chapter, we will first describe the critical role of Notch and NF-κB signals in lymphoid lineages developing in thymus: natural killer T cells, thymocytes, and thymic T regulatory cells. We will address also the role played by ligand expressing cells. Given the importance of Notch/NF-κB cross talk, its role in T-cell leukemia development and progression will be discussed.

Identifiants

pubmed: 32072504
doi: 10.1007/978-3-030-36422-9_10
doi:

Substances chimiques

NF-kappa B 0
Receptors, Notch 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

145-164

Auteurs

G Tsaouli (G)

Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

A Barbarulo (A)

Department of Immunology, Institute of Immunity and Transplantation, Royal Free Hospital, London, UK.

A Vacca (A)

Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.

I Screpanti (I)

Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. isabella.screpanti@uniroma1.it.

M P Felli (MP)

Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy. mariapia.felli@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH